Micro FDA Friday, December 14, 2012 0.00 Neutral

FDA Approves TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Micro Labs Limited

Micro Labs Limited secured FDA approval for its Tramadol Hydrochloride and Acetaminophen oral tablet formulation, expanding its product portfolio in the U.S. pain management market. This regulatory milestone is anticipated to bolster the manufacturer's revenue streams through increased generic sales within the acute pain sector.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day